3Daughters Secures $15M Series A to Revolutionize Women's Contraception with a Frameless, Magnetic IUD!

3Daughters, a trailblazer in clinical development and Evolutionary Healthcare for Women, proudly announced a $15,000,000 funding milestone that will accelerate the advancement of its innovative approach to long-acting contraception. Centered on the development of a frameless, magnetic, and nonhormonal intrauterine device (IUD) grounded in principles of physics and geometry, 3Daughters aims to revolutionize women’s health by addressing the common pitfalls associated with traditional T-shaped IUDs. Conventional devices are often plagued by issues such as pain, perforation, expulsion, and the inconvenience of dangling retrieval strings—all factors that contribute to a pervasive “fear factor” among patients and practitioners alike. With its newly designed IUD, 3Daughters offers a solution that naturally conforms to a woman’s body, eliminates the discomfort and risks tied to outdated designs, and does so with no strings attached. This breakthrough not only promises to diminish the physical and emotional burdens often experienced during IUD insertion and removal but also signifies a proactive step toward reducing the hesitation many women face when considering contraception. The freshly secured investment will be strategically deployed to enhance clinical trials, streamline regulatory processes, and expand both research and educational outreach initiatives. Recognizing that nearly all women will utilize contraception at some point in their lives, 3Daughters is committed to transforming an essential aspect of women’s healthcare, making it safer, more comfortable, and more accessible. This funding round underscores the confidence investors have in the company’s mission to elevate women’s reproductive health through innovative, evidence-based solutions, fostering a future where modern design and thoughtful healthcare intersect seamlessly.